Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection.

scientific article

Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1002/CLC.4960220905
P932PMC publication ID6655822
P698PubMed publication ID10486695
P5875ResearchGate publication ID227841946

P2093author name stringP A Wolf
J H Chesebro
E K Massin
R M Zusman
A Comerota
J R Hartmann
E Raps
P2860cites workThe United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final resultsQ24514937
Clinical Practice Guidelines – Directions for a New ProgramQ26829971
Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) GroupQ28165346
Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research GroupQ28261623
Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) GroupQ28284523
Final report on the aspirin component of the ongoing Physicians' Health StudyQ29619461
Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' CollaborationQ29619529
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering CommitteeQ29620666
Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre StudyQ33396916
Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease statesQ33449857
Aspirin as an antiplatelet drugQ34338650
Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' CollaborationQ70378598
The association of changes in physical-activity level and other lifestyle characteristics with mortality among menQ70544602
The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research groupQ71394626
Antiplatelet therapyQ71396795
Primary prevention of strokeQ71523317
The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study GroupQ71523386
Clinical recommendations using levels of evidence for antithrombotic agentsQ71732636
Antithrombotic therapy in peripheral arterial occlusive diseaseQ71732692
Risk factors for atherosclerotic cardiovascular outcomes in different arterial territoriesQ71916382
Ultrastructural studies of platelet aggregates from human subjects receiving clopidogrel and from a patient with an inherited defect of an ADP-dependent pathway of platelet activationQ71930733
Subclinical Disease as an Independent Risk Factor for Cardiovascular DiseaseQ71974433
Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis StudyQ72171512
Does aspirin consumption affect the presentation or severity of acute myocardial infarction?Q72341929
Aspirin plus either dipyridamole or ticlopidine is effective in preventing recurrent myocardial infarction. Secondary Prevention GroupQ73156505
Aspirin in the treatment and prevention of cardiovascular diseaseQ73324280
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative GroupQ73396117
Antiplatelet effect of ticlopidine after coronary stentingQ73407496
CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative GroupQ73422585
Practice guidelines and prediction rules should be subject to careful clinical testingQ73453473
Are we mortgaging the medical profession?Q95814757
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stentsQ34374902
The gastrointestinal toxicity of aspirin: an overview of randomised controlled trialsQ34403671
The Canadian American Ticlopidine Study (CATS) in thromboembolic strokeQ34462070
A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study GroupQ34540010
Basic data concerning associated coronary disease in peripheral vascular patientsQ36448743
The pathogenesis of coronary artery disease and the acute coronary syndromes (1).Q36728740
The pathogenesis of coronary artery disease and the acute coronary syndromes (2).Q36730913
Randomised trial of prophylactic daily aspirin in British male doctorsQ36894287
A comparison between aspirin and pentoxifylline in relieving claudication due to peripheral vascular disease in the elderlyQ39457551
The appropriateness of carotid endarterectomyQ39631966
Aspirin and other platelet-active drugs. The relationship among dose, effectiveness, and side effectsQ40412076
Antithrombotic therapy for cerebrovascular disorders. An updateQ40412158
New antithromboticsQ40412169
Gastrointestinal bleeding during low-dose aspirin administration for prevention of arterial occlusive events. A critical analysis.Q40414451
Medical compared with surgical treatment of asymptomatic carotid artery stenosisQ40421830
Platelets and Platelet Inhibitors in Acute Myocardial InfarctionQ40430459
Antiplatelet drugs. A comparative reviewQ40432300
Pharmacokinetic optimisation of the treatment of embolic disordersQ40504534
Drugs and surgery in the prevention of ischemic strokeQ40561483
Antithrombotic agents in cerebral ischemiaQ40598000
Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluationsQ40618389
Aspirin, platelets, and thrombosis: theory and practice.Q40716424
New thoughts on strategies for modulating platelet function through the inhibition of surface receptorsQ40924350
Antiplatelet therapy and the prevention of thrombosisQ41067846
Ticlopidine or clopidogrel as alternatives to aspirin in prevention of ischemic strokeQ41158313
New developments in antiplatelet and antithrombotic therapyQ41162547
Acute stroke therapiesQ41169631
The relation between systematic reviews and practice guidelinesQ41551981
Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial.Q42195944
European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of strokeQ42551725
Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell contentQ42578006
Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplastyQ43589719
Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile GroupQ43622066
Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).Q44493271
Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclaseQ44955459
Evidence-based disease managementQ46621850
Mortality over a period of 10 years in patients with peripheral arterial diseaseQ46786119
Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age.Q48094539
Cerebral ischemia and asymptomatic coronary artery disease: a prospective study of 83 patientsQ48278309
Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. The Asymptomatic Cervical Bruit Study Group.Q50594716
Detailed diagnoses and procedures, National Hospital Discharge Survey, 1995.Q50914202
An analysis of perioperative surgical mortality and morbidity in the asymptomatic carotid atherosclerosis study. ACAS Investigators. Asymptomatic Carotid Atherosclerosis Study.Q51556185
Tissue factor modulates the thrombogenicity of human atherosclerotic plaques.Q52523874
Development of aspirin resistance in persons with previous ischemic stroke.Q54189504
Aspirin in coronary heart disease. The Coronary Drug Project Research GroupQ67242605
States of insulin resistance: the interaction between hypertension, glucose intolerance, and coronary heart disease. Proceedings of a symposium. Montreal, Canada, June 24, 1990Q68294900
Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative GroupQ68323492
RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2Q69755626
Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirinQ69875861
Multicenter double-blind study of ticlopidine in the treatment of intermittent claudication and the prevention of its complicationsQ70212920
A prospective study of aspirin use and primary prevention of cardiovascular disease in womenQ70215146
P433issue9
P304page(s)559-573
P577publication date1999-09-01
P1433published inClinical CardiologyQ4502312
P1476titleAntiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection
P478volume22